12:00 - 12:55 PM

Check-in and Networking Lunch

12:55 - 1:00 PM

Welcome & Opening Remarks

Presented By:
Craig Simak, CEO & Co-Founder - OIS

1:00 - 1:40 PM

The Rockstars of Ophthalmic Innovation

A panel of serial entrepreneurs share the secrets to their success and lessons learned the hard way.



Michael Ackermann, PhD
Co-Founder, Oculeve, Oyster Point Pharma & Tarsus Pharmaceuticals

Mark Blumenkranz, MD
Founder, Optimedica, Adverum Biotechnologies, Verana Health and Kedalion Therapeutics

Thomas Chalberg, PhD
Founder & CEO - Avalanche Biotech / Founder & CEO - SightGlass Vision / Founder & Chairman - iRenix / Founder - Exhaura Ltd

Eugene de Juan, MD
Co-Founder, Azura, Second Sight, InnoRx, NeoVista, Retina Lab, Transcend Medical & ForSight VISION 1- 6

Sean Ianchulev, MD, MPH
Founder, Iantrek, miLOOP, and Eyenovia

Jerry St. Peter
Founder of Eyevance Pharmaceuticals and CEO of Xequel Bio


Moderated By:
Bill Link, PhD, Founder, American Medical Optics and Chiron Vision

1:40 - 1:50 PM

Innovation in Clinical Trials – Using AI in OCT Scans

Presented By:
George Magrath, MD, MBA, CEO - Lexitas Pharma Services

1:50 - 3:00 PM

Innovation Showcase

Eliksa Therapeutics | Armen Karamanian, MD, PhD, CEO
Citrus Therapeutics | David Almeida, MD, MBA, PhD, Co-Founder
Formosa Pharmaceuticals | Erick Co, PhD, CEO
GelMEDIX | Art Driscoll, Chief Development Officer
Eye-Go | Henrik Nagel, CEO
Xequel Bio | Jerry St. Peter, CEO
Avisi Technologies | Rui Jing Jiang, Co-Founder & CEO
Betaliq | Barry Butler, President & CEO
Pykus Therapeutics | Sameer Sabir, Executive Chairman

3:00 - 3:30 PM

Investing & Raising Capital in a Bear Market

How are VCs and start-ups navigating a down market?

James Murray, Partner - ExSight Ventures
Jeffry Weinhuff, Managing Partner - Visionary Venture Fund
Ron Weiss, MD, Managing Partner - InFocus Capital Partners
Tyler Stowater, Partner - Bluestem
Klaus Stöckemann, PhD, MBA, Managing Partner & Co-Founder - Peppermint VenturePartners


Moderated By:
Mina Sooch, Founder & CEO - Ocuphire Pharma

3:30 -  3:55 PM

Networking Break

3:55 - 4:45 PM

Spotlight on Neuroprotection

Oculis | Riad Sherif, MD, CEO
Stuart Therapeutics | Eric Schlumpf, President & CEO
InGel Therapeutics | Michael Young, PhD, FARVO, Co-founder & Chairman of SAB


Expert Perspectives

Sharon Bakalash, MD, PhD, CBA, Founder & CEO - SB Strategic Development Consultants
Gustavo De Moraes, MD, PhD, MPH, Chief Medical Officer - Ora / Associate Professor of Clinical Ophthalmology, Department of Ophthalmology - Columbia University Medical Center, New York Presbyterian Hospital
Ehsan Sadri, MD, CEO & Founder - Visionary Eye Institute / Founding Board Member - Visionary Venture Fund


Moderated By:
Robert Rothman, MD, Co-Founder and Managing Member - InFocus Capital Partners / Partner, OCLI/Glaucoma Consultants of Long Island

4:45 - 5:15 PM

Maximizing OD/MD Market Potential and How to Achieve Commercial Success with a New Product

Aziz Mottiwala, Chief Commercial Officer - Tarsus Pharmaceuticals
Jeffrey Nau, PhD, President & CEO - Oyster Point Pharma
Carey Powers, Global Head of Corporate Marketing - Avellino
Tony Tipton, Chief Operating Officer - Xequel Bio

Moderated By:
Robert Dempsey, President & CEO - AsclepiX Therapeutics

5:15 - 6:30 PM

Networking Reception


7:00 - 8:30 AM

Networking Breakfast & Check-in

7:30 - 8:30 AM

Breakfast Breakout - Spotlight on Myopia

Topcon | Jonathan Liu, Senior Director, Business Development
NovaSight | Liron Rosenbaum, VP, Strategy
Sydnexis | Patrick Johnson, PhD, President

Expert Perspectives

Robert A Clark, MD - South Bay Family Eye / Associate Clinical Professor of Ophthalmology - Stein Eye Institute
Rajeev Garg, PhD, Global Head, Myopia Management Strategy – CooperVision
Matt Oerding, Board Member - GMAC / CEO & Co-Founder - Treehouse Eyes

Moderated By:
David Kading, OD, FAAO, FCLSA, CEO - Specialty Eye

7:30 - 8:30 AM

Breakfast Breakout - Spotlight on Gene & Cell Therapy

Ray Therapeutics | Peter Francis, MD, PhD, CMO
Adverum Biotechnologies | Laurent Fischer, MD, President & CEO

Expert Perspectives

Thomas Ciulla, MD, MBA, Chief Medical Officer & Chief Development Officer - Clearside Biomedical / Clinical Professor of Ophthalmology, Volunteer - Indiana University School of Medicine / Vitreoretinal Medicine and Surgery - Midwest Eye Institute
Kali Stasi, MD, PhD, Principal, Innoviama Consulting / Founder and Scientific Advisor - Diorasis Therapeutics
Henry Wiley, MD, Lead Medical Director - Genentech

Moderated By:
Amy Laster, PhD, SVP, Science Strategy & Awards - Foundation Fighting Blindness

8:40 - 9:00 AM

View from the NEI

Presented By:
Michael F. Chiang, MD, Director - National Eye Institute, National Institutes of Health

9:00 - 10:10 AM

Anterior Innovation Showcase

Stuart Therapeutics | Eric Schlumpf, President & CEO
Tarsier Pharma | Daphne Haim-Langford, PhD, CEO & Chairperson
Avellino | Jon Robson, President & CEO
TherOptix | Monty Montoya, CEO
Glaukos | Tomas Navratil, Chief Development Officer
Trefoil Therapeutics | David Eveleth, PhD, CEO & Co-Founder
Trukera Medical | Adam Szaronos, CEO
Novaliq | Christian Roesky, PhD, CEO
Tarsus Pharmaceuticals | Aziz Mottiwala, Chief Commercial Officer

10:10 - 10:45 AM

Morning Networking Break

10:45 - 11:40 AM

Spotlight on Dry Eye

Surface Ophthalmics | Kamran Hosseini MD, PhD, President & CEO
TearSolutions | Marc Odrich, MD, CMO
Azura Ophthalmics Limited | Marc Gleeson, CEO
Dompé | Georgea Pasedis, Senior Vice President Global Medical Affairs

Expert Perspectives

Robert Dempsey, CEO & President - AsclepiX Therapeutics
Cecelia Koetting, OD, FAAO - Intrepid Eye Society
Marian Macsai, MD, Chief Medical Officer, Medical Affairs - Oyster Point Pharma
Michael E. Stern, PhD, Founding Member- ImmunEyez

Moderated By:
Joseph Tauber, MD - Tauber Eye Center

11:40 - 12:50 PM

Retina Innovation Showcase

Ocuphire Pharma | Mina Sooch, Founder & CEO
Outlook Therapeutics | Russ Trenary, President & CEO
Valitor | Wesley M. Jackson, President & Chief Scientific Officer
Envision Diagnostics | Alex Walsh, MD, President & CEO
Ocular Therapeutix | Andrew Moshfeghi, MD, MBA
Re-Vana Therapeutics | Michael O’Rourke, CEO
Ripple Therapeutics | Tom Reeves, President & CEO
Clearside Biomedical | Thomas Ciulla, MD, MBA, Chief Medical Officer & Chief Development Officer
Annexin Pharmaceuticals | Anna Frostegard, MD, PhD, Chief Scientific and Medical Officer
ForwardVue Pharma | Bob Katz, CEO & President

12:50 - 1:45 PM

Networking Lunch

1:45 - 2:45 PM

Spotlight on Dry AMD & GA

Presented By:
Claire Gelfman, PhD, Chief Scientific Officer - Foundation Fighting Blindness

Iveric Bio | Julie Clark, MD, VP, Clinical Development
ONL Therapeutics, Inc. | David Esposito, CEO
Aviceda Therapeutics | Michael Tolentino, MD, Chief Technology Officer
LumiThera | Clark Tedford, PhD, President & CEO

Expert Perspectives

Manuel Amador, MD, Medical Director, Medical Affairs Ophthalmology - Genentech
William Freeman, MD, Vice Chairman, Department of Ophthalmology & Director, Jacobs Retina Center - Shiley Eye Institute of the University of California San Diego
Andrew Moshfeghi, MD, MBA - USC Keck School of Medicine
Nadia K. Waheed, MD, MPH - Tufts Medical Center

Moderated By:
Claire Gelfman, PhD, Chief Scientific Officer - Foundation Fighting Blindness

2:45 - 2:55 PM

Private Funding Trends

Presented by:
Jonathan Norris, Managing Director - Silicon Valley Bank

2:55 - 3:05 PM

Public Market Overview

Presented By:
Cameron Taylor, Managing Director - BofA Securities | Life Sciences

3:05 - 3:35 PM

Navigating the Public Markets for Ophthalmology Companies

Paul Bresge, CEO - Ray Therapeutics
Rael Mazansky, MD, MBA, Managing Director – Deep Track Capital
Annabel Samimy, Managing Director, Biopharmaceuticals - Stifel Financial Corp.
Cameron Taylor, Managing Director - BofA Securities | Life Sciences
Chen Yu, MD, MBA, Managing Partner - TCG Crossover


Moderated By:
Pravin U. Dugel, MD, President - Iveric Bio

3:35 - 4:00 PM

Networking Break

4:00 - 4:30 PM

Medicine in the Metaverse

Michael F. Chiang, MD, Director - National Eye Institute, National Institutes of Health
Pam Nesbitt, Global Chief Architect for Healthcare & Life Sciences - Microsoft
Khizer Khaderi, MD, MPH, Founder & Director - The Human Perception Lab at Stanford / Founder & CEO - Vizzario

Moderated By:
Ranya Habash, MD, Co-Founder, MΞTAMΞD / FDA Digital Health Network of Experts/ Medical Director, Technology Innovation - Bascom Palmer Eye Institute / Visionary Innovation Mentor - Stanford University

4:30 - 5:00 PM

The Shifting Strategic Landscape

Anthony Wallace, VP & General Manager, U.S. Surgical - Bausch + Lomb
Paul Hallen, VP & Global Head, Retina - Alcon
Gianluca Rossetti, Strategic Planning & Corporate Business Development Director - Dompè
Andrew Stewart, General Manager, Global Eye Care - AbbVie


Moderated by:
Firas Rahhal, MD, Partner - ExSight Ventures & Retina Vitreous Associates Medical Group

5:00 - 7:00 PM

Networking Reception